NEW YORK (GenomeWeb News) – The US Centers for Disease Control and Prevention has licensed DNAStar’s sequence analysis software for use at several of its facilities, the bioinformatics company said today.
 
The multi-site license agreement allows the CDC’s Coordinating Center for Infectious Disease to use the company’s Lasergene software at its Atlanta base and at its campuses in Colorado, Alaska, and in Puerto Rico.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.